Prospectus

Emmaus Life Sciences, Inc. Filed 2017-07-17 Acc 0001615774-17-003676

Documents 1

2017-07-19 4 Director bought 10,000 shares at an average $4.47 ($44,695)
2017-07-18 4 Options or other derivatives
2017-07-18 4 Options or other derivatives
2017-07-18 4 Director acquired 25,000 shares (grant or award)
2017-07-17 424B4 Prospectus
2017-07-14 8-K Material agreement · Executive or director change · Bylaws or fiscal year change · Other events
2017-07-13 CERTNAS Certification by the Nasdaq Stock Market

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading s106823_424b4.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…